About Klinikum Bremen Nord
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Incyte Corporation
1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
1
Clinical Trials at Klinikum Bremen Nord
During the past decade, Klinikum Bremen Nord conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer
2018-09-28
2023-12-15
Active, not recruiting
124
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma
2019-06-03
2028-07-27
Recruiting
434
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Bremen Nord"
#1 collaborator was "STABIL - Statistische und Biometrische Lösungen" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "Trium Analysis Online GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Klinikum Bremen Nord
According to Clinical.Site data, the most researched conditions in "Klinikum Bremen Nord" are
"Colorectal Cancer" (1 trials), "Metastatic Cholangiocarcinoma" (1 trials) and "Unresectable Cholangiocarcinoma" (1 trials). Many other conditions were trialed in "Klinikum Bremen Nord" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Bremen Nord
Most popular intervention types in "Klinikum Bremen Nord" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Aflibercept + mLV5FU2" (1 trials), "Cisplatin" (1 trials), "Gemcitabine" (1 trials), "Pemigatinib" (1 trials) and "mFOLFOX7" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Bremen Nord
The vast majority of trials in "Klinikum Bremen Nord" are
2 trials for "All" genders.
Clinical Trials Status at Klinikum Bremen Nord
Currently, there are NaN active trials in "Klinikum Bremen Nord".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Klinikum Bremen Nord,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Bremen Nord, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".